SCHEMBL7183840

SCHEMBL7183840

CCCc1ccc(CCc2ccc(-c3cc(F)c(F)c(F)c3)c(F)c2)c(F)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 1/20 0.37
CNR2 P34972 1/20 0.37
ALOX5 P09917 2/20 0.36
RARB P10826 3/20 0.36
HTR2A P28223 1/20 0.33
HTR2C P28335 1/20 0.33
PDK2 Q15119 1/20 0.33
GABRA1 P14867 3/20 0.33
GABRB2 P47870 3/20 0.33
NPC1 O15118 1/20 0.33
TP53 P04637 1/20 0.33
PKM P14618 1/20 0.33
RAB9A P51151 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
HSD17B10 Q99714 1/20 0.33
S1PR1 P21453 1/20 0.32
NR3C2 P08235 1/20 0.32
CHKA P35790 1/20 0.32
RARA P10276 1/20 0.30
RARG P13631 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17487628 0.91 ALOX5 (0.36) CNR1CNR2ALOX5RARBPDK2
SCHEMBL7183626 0.91 RARB (0.42) CNR1CNR2ALOX5RARBPDK2
SCHEMBL16258065 0.91 CNR1 (0.43) CNR1CNR2ALOX5RARBPDK2
SCHEMBL17487870 0.88 RARB (0.40) CNR1CNR2ALOX5RARBGABRA1
SCHEMBL17487803 0.88 ALOX5 (0.38) CNR1CNR2ALOX5RARBHTR2A
SCHEMBL17487685 0.85 ALOX5 (0.38) CNR1CNR2ALOX5RARBPDK2
SCHEMBL17487670 0.85 RARB (0.39) CNR1CNR2ALOX5RARBPDK2
SCHEMBL17487800 0.85 ALOX5 (0.37) CNR1CNR2ALOX5RARBHTR2A
SCHEMBL17487557 0.84 CTSL (0.36) CNR1CNR2ALOX5RARBHTR2A
SCHEMBL17487893 0.83 ALOX5 (0.36) CNR1CNR2ALOX5RARBHTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-10101599-A None JP disclosed
US-6579577-B2 High voltage holding ratio which has a very small degree of temperature dependence, a low threshold voltage CHISSO CORPORATION (JP) 2003-06-17 US disclosed
US-20020166994-A1 Substituted benzene derivative, liquid crystal composition, and liquid crystal display element CHISSO CORPORATION (JP) 2002-11-14 US disclosed
EP-0934919-A1 SUBSTITUTED BENZENE DERIVATIVE, LIQUID-CRYSTAL COMPOSITION, AND LIQUID-CRYSTAL DISPLAY ELEMENT CHISSO CORPORATION (JP) 1999-08-11 EP disclosed
JP-H10101599-A SUBSTITUTED BENZENE DERIVATIVE, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY ELEMENT CHISSO CORP 1998-04-21 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020166994-A1 Substituted benzene derivative, liquid crystal composition, and liquid crystal display element OCIAD2, OCIAD1, POU2F1 CNR1 1937/4885CNR2 1925/4885ALOX5 1967/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.